Matthew W. Quinn

Induction of type-1 diabetes mellitus in laboratory rats by use of alloxan: route of administration, pitfalls, and insulin treatment.

Isaac F Federiuk, Heather M Casey, Matthew W. Quinn et al. · PubMed · 2004 · 153 citations

Laboratory Rats, Drug-induced Diabetes, Insulin Signaling +16

Maternal serum glycosylated fibronectin as a point-of-care biomarker for assessment of preeclampsia

Juha Räsänen, Matthew W. Quinn, Amber Laurie et al. · American Journal of Obstetrics and Gynecology · 2014 · 64 citations

Gynecology, Gestational Diabetes, Maternal Health +9

Vascularizing the tissue surrounding a model biosensor: how localized is the effect of a subcutaneous infusion of vascular endothelial growth factor (VEGF)?

W. Kenneth Ward, Matthew W. Quinn, Michael D. Wood et al. · Biosensors and Bioelectronics · 2003 · 55 citations

Tissue Engineering, Angiogenesis, Engineering +11

Elevation of transforming growth factor beta (TGFβ) and its downstream mediators in subcutaneous foreign body capsule tissue

Allen G. Li, Matthew W. Quinn, Yasmin Siddiqui et al. · Journal of Biomedical Materials Research Part A · 2007 · 42 citations

Passivating protein coatings for implantable glucose sensors: Evaluation of protein retention

Steven J. Geelhood, Thomas A. Horbett, W. Kenneth Ward et al. · Journal of Biomedical Materials Research Part B Applied Biomaterials · 2006 · 42 citations